Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On this page, we’ll discuss an overview of the new Suboxone lawsuit, tooth decay side effects linked to Suboxone, who qualifies to file a Suboxone lawsuit, and much more.
Suboxone is a prescription drug manufactured by Indivior used to treat opioid addiction.
The drug contains two active ingredients:
While these drugs have been used for decades, they have recently been linked to serious health problems, including addiction, dependency, and death.
If you or a loved one has experienced side effects from Suboxone, contact TorHoerman Law today using the chat on this page for a free consultation.
The Suboxone lawsuit has seen several crucial developments, particularly around the issue of tooth decay claims.
Plaintiffs argue that if they had been aware of these risks, they could have taken preventive measures or chosen alternative treatments
Here’s a summary of the latest suboxone lawsuit updates:
The core of these lawsuits is the claim that Indivior failed to adequately warn users of the risks of severe tooth decay and other dental problems associated with Suboxone, particularly before adding a warning in 2022.
In the last two weeks of November 2023 alone, 14 new Suboxone product liability lawsuits were filed in federal courts.
Of these, eight were filed in the Northern District of Ohio, which currently holds the most pending Suboxone cases of any district.
The U.S. Judicial Panel on Multidistrict Litigation is set to consider consolidating 15 lawsuits related to Suboxone tooth decay claims.
These lawsuits were filed in five different jurisdictions.
The lawsuits allege that Indivior, the manufacturer of Suboxone, failed to adequately warn users about the potential dental side effects, such as tooth decay, tooth loss, infections, cracked teeth, and cavities.
This settlement reached by U.S. lawmakers claimed that Indivior illegally suppressed generic competition.
In October 2023, Indivior agreed to pay $385 million to settle Suboxone lawsuits filed by drug wholesalers.
This settlement was reached with U.S. lawmakers and resolved claims that Indivior illegally suppressed generic competition for Suboxone.
In a widespread settlement involving 41 states and the District of Columbia, Indivior has agreed to pay $102.5 million.
This settlement addresses issues related to Indivior’s business practices and the impact on Suboxone’s availability and pricing in these states.
Regarding the settlement involving 41 states and the District of Columbia, where Indivior agreed to pay $102.5 million, the available information from the sources does not specifically confirm this detail.
However, it is noted that Indivior and Reckitt Benckiser faced various legal challenges, including an antitrust class-action lawsuit and settlements with the Federal Trade Commission totaling $60 million, related to deceptive marketing practices and limiting generic competition for Suboxone.
The lawsuits primarily revolve around the allegations that Indivior, the manufacturer of Suboxone, failed to warn about the risks of dental injuries.
This move comes in the wake of numerous reports of severe tooth decay experienced by Suboxone users.
Key points to consider about the suboxone lawsuit include:
The Suboxone lawsuit is a significant legal matter due to its assertions about the drug’s adverse effects and the manufacturer’s alleged failure to inform.
This allegation is critical as it can potentially affect current and future patients, healthcare professionals, and the pharmaceutical industry.
Suboxone is a medication used to aid individuals struggling with opioid addiction.
However, many people have reported severe dental issues, including tooth decay, erosion, dry mouth, gum problems, tooth fractures, and infections, as a result of taking Suboxone.
The lawsuits claim that the manufacturer, Indivior, did not adequately warn people about the risk of dental problems associated with the medication.
Some studies have suggested a link between Suboxone use and dental issues, and the FDA has issued warnings about the dental risks of the medication.
The statute of limitations for filing a suboxone lawsuit related to health conditions such as tooth decay varies from state to state.
Those who have suffered psychologically, emotionally, or financially due to these issues, contact TorHoerman Law using the chat on this page for an instant case evaluation.
Suboxone litigation involves navigating complex medical and legal landscapes to advocate for clients’ rights.
Understanding the health conditions linked to Suboxone is crucial for building a strong legal case.
Health conditions potentially associated with Suboxone include:
Patients who have been prescribed Suboxone as part of their treatment plan may not have been fully informed of the potential risks associated with its use.
TruLaw is actively investigating claims that the manufacturer of Suboxone failed to provide adequate warnings about the dangers of the drug, which could have led to preventable injuries or even fatalities.
Determining who qualifies to file a Suboxone lawsuit is a critical step in seeking justice.
Individuals may qualify for a Suboxone lawsuit if they:
TruLaw’s legal team is skilled at assessing the merits of a potential Suboxone lawsuit, taking into account the specifics of each individual’s circumstances.
The firm’s attorneys work closely with medical experts to establish causation between Suboxone use and the client’s health issues, which is a crucial element in building a successful legal claim.
Average settlement amounts in Suboxone litigation can vary based on the details of each case.
Factors influencing settlement amounts include:
While settlements in Suboxone litigation can provide financial relief to those affected, they also serve a broader purpose.
They can act as a deterrent to pharmaceutical companies, encouraging them to prioritize patient safety and transparency.
TruLaw is committed to securing fair compensation for its clients and holding negligent parties accountable for their actions.
Staying informed about both upcoming and past legal proceedings is essential for those involved in Suboxone litigation.
These settlements have significant implications for those prescribing Suboxone, especially concerning the availability of generic Suboxone tablets and sublingual strips.
Details of previous Suboxone litigations include:
From 2010 to 2014, the United States alleges that RB Group, through its branches, engaged in questionable practices with Suboxone.
The allegations against RB Group include:
The questionable practices leading up to the ongoing suboxone litigations focused on false marketing claims and the drug’s impact, like severe tooth decay and dental erosion.
Suboxone lawyers at TruLaw are closely monitoring this case, as it involves serious allegations of false marketing and its impact on those using Suboxone for reducing withdrawal symptoms.
The federal court’s involvement underscores the gravity of these allegations and their potential impact on public health and healthcare costs.
These investigations reveal that patients using Suboxone experience a higher frequency of dental issues like cavities, tooth decay, and gum disease compared to those using other opioid dependency treatments.
The acidic nature of Suboxone, particularly when dissolved in the mouth, is believed to weaken tooth enamel and detrimentally impact oral health over time.
Key studies and publications on Suboxone dental injuries include:
The studies and reports collectively underscore the need for increased awareness and precautionary measures for patients using Suboxone, especially those with pre-existing dental issues or at higher risk of dental complications.
Buprenorphine-containing medicines are approved to treat opioid use disorder (OUD), and one product is approved to treat pain.
These medicines are available as single-ingredient products and in combination with naloxone.
Buprenorphine medicines are marketed under the brand names:
They are also available as generics.
Buprenorphine is an opioid and works by changing the way the brain and nervous system respond to pain.
In patients taking buprenorphine for OUD, it reduces opioid withdrawal symptoms and the desire to use opioids without causing the cycle of highs and lows associated with opioid misuse or abuse.
At proper doses, buprenorphine also decreases the pleasurable effects of other opioids, making continued opioid use less appealing.
When combined with counseling and other behavioral therapies, this comprehensive medication-assisted treatment (MAT) approach is often the most effective way of treating OUD.
It can help sustain recovery and prevent or reduce opioid overdose
Common side effects of buprenorphine include:
The use of buprenorphine drugs, particularly those dissolved orally like Suboxone sublingual films and strips, has surged in recent years.
From 2014 to 2020, the number of these prescriptions dispensed in the United States climbed from 11 million to 16 million.
A concerning number of dental problems have been linked to these medications:
The onset and impact of these dental issues vary:
The nature of dental treatments highlights the severity of these issues:
These findings raise significant legal and regulatory concerns:
The Suboxone lawsuit marks a critical development in addressing opioid crisis complexities, particularly focusing on the consequences of Suboxone used in opioid dependence treatment.
Victims affected by Suboxone may find the following aspects of the lawsuit particularly relevant:
This lawsuit brings to light significant issues for the implicated companies:
The lawsuit could lead to broader implications in the industry:
The range of reported dental injuries highlights significant concerns:
This lawsuit extends beyond individual claims, affecting the entire pharmaceutical sector:
In summary, the Suboxone lawsuit is a significant milestone, not just for the victims seeking justice but also for the broader implications it holds for pharmaceutical practices, legal standards, and patient safety in the context of opioid addiction treatment.
TruLaw offers unparalleled expertise and advocacy in Suboxone litigation services.
Our team of experienced attorneys is well-versed in the complexities of pharmaceutical litigation, providing our clients with the support they need to navigate their legal challenges.
TruLaw provides comprehensive Suboxone litigation services:
Partnering with TruLaw ensures that clients receive informed and strategic legal counsel in the area of Suboxone litigation.
Our dedication to staying at the forefront of legal development enables us to offer advice that is not only current but also forward-thinking.
Whether you are facing a Suboxone dispute or seeking to understand your legal options, TruLaw is your trusted partner in pharmaceutical litigation.
Staying informed and prepared is essential for success.
With the support and guidance of TruLaw, clients can confidently face the challenges of Suboxone litigation and secure their legal rights.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Suboxone Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Miami, Florida-based Infinite Herbs LLC has recalled 2.5-ounce packages of Infinite Herbs-branded fresh organic basil bearing UPC 8 18042 02147 7 and that were made available for purchase between February 1 and April 6, 2024 because of a potential Salmonella contamination. While healthy individuals infected
According to the FDA, InfuTronix LLC has recalled the Nimbus Administration Set, Flex, and PainPro (also known as the Halo Ambulatory Infusion System), in addition to the Nimbus II PainPRO, Flex, Plus, EpiD, and EMS infusion pumps, due to several potential modes of product failure.
Gibson Farms of Hollister, California said it has recalled its Organic Light Halves and Pieces shelled walnuts after receiving information that the products may have the potential to be contaminated with E. Coli 0157:H7, according to the FDA. E. coli O157:H7 causes a diarrheal illness